NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Treatment of Anxiety in Pregnancy Study
Treatment of Anxiety in Pregnancy Study

NCT05064254

CompletedNA

Sponsor: Sunnybrook Health Sciences Centre

Conditions: Anxiety, Pregnancy

Interventions: Treatment as usual (TAU), Mindful Adaptive Practice in Pregnancy Therapy

Countries: Canada

Anxiety Disorders or Depressive Disorders with anxiety, affect about 3/5 pregnancies. It is known that if left untreated, these disorders are associated with poor delivery outcomes, ongoing mental illness, and negative effects on the child. The COVID-19 pandemic has created heightened anxiety in many people especially the most vulnerable. As a result, the investigators have seen that pregnant women report even higher rates of anxiety than in the past. Talk therapy is recommended but is underused in part because it takes a long time to learn and use. The COVID crisis has added another layer of complexity in that in-person treatment is not routinely available. The investigator team has adapted a talk therapy treatment, "Mindful adaptive practice in pregnancy (MAPP)" where women are taught skills to reduce anxiety. This treatment is done virtually over the internet in a synchronous group format. The overall objective of this study is to assess the feasibility, acceptability, and adherence to the clinical trial protocol evaluating MAPP on anxiety symptoms among pregnant women. This synchronous virtual treatment is novel and has the potential to change clinical practice as it will effectively reduce anxiety, takes a short time to learn and women will have access to it regardless of living in rural or remote areas. The results of this study will guide the development of a larger multi-site randomized controlled trial (RCT).

Eligibility overview

Sex: FEMALE

Age: 18 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Pregnant
* \>18 years of age
* At 12-30weeks gestation
* Score \> 7 on the GAD-7
* Have internet access with camera, microphone, and ability to run the necessary software.
* Fluent in written and spoken English
* Willing to provide the name and contact details of their primary health care provider / other contact who would know person's whereabouts.

Exclusion Criteria:

* Current substance use
* Current psychotic/manic symptoms
* Active suicidal ideation
* Current use of psychotropic medication with dose change within 4 weeks of recruitment
* Currently receiving psychotherapy
* Unwilling to be randomized.
Locations (2)
  • Toronto, Ontario, Canada
  • Toronto, Ontario, Canada